MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Ocular Therapeutix Company Profile (NASDAQ:OCUL)

Consensus Ratings for Ocular Therapeutix (NASDAQ:OCUL) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $46.40 (175.21% upside)

Analysts' Ratings History for Ocular Therapeutix (NASDAQ:OCUL)
Show:
DateFirmActionRatingPrice TargetActions
8/13/2015Morgan StanleyInitiated CoverageOverweight$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015NomuraInitiated CoverageBuy$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/13/2015BTIG ResearchInitiated CoverageBuy$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2015RBC CapitalLower Price TargetOutperform$50.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2015OppenheimerBoost Price TargetOutperform$42.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2015RBC CapitalBoost Price TargetOutperform$35.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015OppenheimerBoost Price TargetOutperform$25.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014Cowen and CompanyInitiated CoverageOutperform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014OppenheimerInitiated CoverageOutperform$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014RBC CapitalInitiated CoverageOutperform$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/2/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha